Omeprazole (Prilosec, Zegerid) and Black patients
Brand names: Prilosec, Zegerid
What Omeprazole does
Omeprazole blocks the gastric acid pump, dramatically reducing stomach acid. It's available over-the-counter for short courses of heartburn, and prescription for GERD, ulcers, and esophagitis.
What the evidence says for Black patients
No race-specific efficacy differences. But two equity-adjacent issues:
- CYP2C19 metabolism. Omeprazole is activated by CYP2C19. Poor metabolizers (more common in some Asian populations; present but less common in Black populations) have higher omeprazole plasma levels and more acid suppression. Most patients don't need dose adjustment, but the clopidogrel interaction (omeprazole inhibits CYP2C19 and reduces clopidogrel activation) is documented — see the clopidogrel page.
- Long-term PPI use. Associations with kidney disease, bone fracture, B12 deficiency, and C. difficile are reported. Given the disproportionate CKD and fracture burden in aging Black populations, deprescribing PPIs when no longer needed is a high-value intervention.
Common alternatives
Pantoprazole, esomeprazole — other PPIs with different pharmacokinetic profiles. H2-blockers (famotidine) for mild reflux. Lifestyle modifications (weight loss, elevation of head of bed, avoiding late meals).
Side effects
- Headache, GI upset
- B12 deficiency (long-term)
- Magnesium deficiency
- Increased risk of pneumonia, C. difficile
- Bone fracture (long-term)
- Small CKD risk (long-term)
- Rebound acid hypersecretion on discontinuation
Factors that affect adherence
Take 30 minutes before breakfast. Generic OTC omeprazole is inexpensive. Re-evaluate need annually — chronic PPI use is often continued out of inertia.
Questions to ask your doctor
Bring this list to your next appointment.
- Do I still need this, or can we try stopping?
- If I'm on clopidogrel, does the drug interaction matter for me?
- Am I at risk for B12 or magnesium deficiency from long-term use?
References
- Xie Y, Bowe B, Li T, et al. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Kidney Int. 2017;91:1482–1494.
- Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: AGA expert review. Gastroenterology. 2017;152:706–715.
- U.S. Food and Drug Administration. Prilosec (omeprazole) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019810s096lbl.pdf
Medical disclaimer
This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.
Read our editorial standards for how we source, review, and update these pages.